Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Andrzej Mackiewicz, Jacek Mackiewicz, Piotr J. Wysocki, Maciej Wiznerowicz, Malgorzata Kapcinska, Maria Laciak, Stefan Rose-John, Dariusz Izycki, Tomasz Burzykowski & Aldona Karczewska-Dzionk. (2012) Long-term survival of high-risk melanoma patients immunized with a Hyper-IL-6-modified allogeneic whole-cell vaccine after complete resection. Expert Opinion on Investigational Drugs 21:6, pages 773-783.
Read now
Read now
P J Wysocki, J Zolnierek, C Szczylik & A Mackiewicz. (2007) Recent developments in renal cell cancer immunotherapy. Expert Opinion on Biological Therapy 7:5, pages 727-737.
Read now
Read now
Articles from other publishers (16)
Nurliyana Mohd Yusof, Natasha Nurafiqah Mohamed Noor Fuadi, Muhajir Hamid, Noorjahan Banu Mohamed Alitheen, Nursyuhaida Mohd Hanafi & Nik Mohd Afizan Nik Abd Rahman. (2022) Interleukin-27 Disrupts the Crosstalk of Apoptotic Activities between 4T1 Breast Cancer Cells and M2 Macrophages. Malaysian Journal of Medicine and Health Sciences 18:6, pages 125-133.
Crossref
Crossref
Sharada Mokkapati, Vikram M. Narayan, Ganiraju C. Manyam, Amy H. Lim, Jonathan J. Duplisea, Andrea Kokorovic, Tanner S. Miest, Anirban P. Mitra, Devin Plote, Selvalakshmi Selvaraj Anand, Michael J. Metcalfe, Kenneth DunnerJr.Jr., Burles A. Johnson, Bogdan A. Czerniak, Tiina Nieminen, Tommi Heikura, Seppo Yla-Herttuala, Nigel R. Parker, Kimberley S. Schluns, David J. McConkey & Colin P. Dinney. (2022) Lentiviral interferon: A novel method for gene therapy in bladder cancer. Molecular Therapy - Oncolytics 26, pages 141-157.
Crossref
Crossref
Ivan S. Pires, Paula T. Hammond & Darrell J. Irvine. (2021) Engineering Strategies for Immunomodulatory Cytokine Therapies: Challenges and Clinical Progress. Advanced Therapeutics 4:8, pages 2100035.
Crossref
Crossref
Jonathan J. Duplisea, Sharada Mokkapati, Devin Plote, Kimberly S. Schluns, David J. McConkey, Seppo Yla-Herttuala, Nigel R. Parker & Colin P. Dinney. (2018) The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside. World Journal of Urology 37:10, pages 2041-2049.
Crossref
Crossref
Giada Mondanelli, Claudia Volpi, Roberta Bianchi, Massimo Allegrucci, Vincenzo Nicola Talesa, Ursula Grohmann & Maria Laura Belladonna. (2015) Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. Cytokine 75:2, pages 380-388.
Crossref
Crossref
Ewa Leporowska. (2012) Wybrane parametry laboratoryjne w monitorowaniu chorych immunizowanych genetycznie modyfikowaną szczepionką przeciwczerniakową. Zeszyty Naukowe WCO, Letters in Oncology Science 9:4, pages 183-193.
Crossref
Crossref
Michela Croce, Maria Valeria Corrias, Anna Maria Orengo, Antonella Brizzolara, Barbara Carlini, Martina Borghi, Valentina Rigo, Vito Pistoia & Silvano Ferrini. (2010)
Transient depletion of CD4
+
T cells augments IL‐21‐based immunotherapy of disseminated neuroblastoma in syngeneic mice
. International Journal of Cancer 127:5, pages 1141-1150.
Crossref
Crossref
P J Wysocki, U Kazimierczak, W Suchorska, M Kotlarski, J Malicki & A Mackiewicz. (2010) Gene-modified tumor vaccine secreting a designer cytokine Hyper-Interleukin-6 is an effective therapy in mice bearing orthotopic renal cell cancer. Cancer Gene Therapy 17:7, pages 465-475.
Crossref
Crossref
Zhiming Hu, Wanlong Tan, Lin Zhang, Zhongkun Liang, Cuixiang Xu, Hua Su, Jianxin Lu & Jimin Gao. (2009) A novel immunotherapy for superficial bladder cancer by intravesical immobilization of GM-CSF. Journal of Cellular and Molecular Medicine 14:6b, pages 1836-1844.
Crossref
Crossref
Tae S. Kim, Byeong C. Lee, Eugene Kim, Daeho Cho & Edward P. Cohen. (2008) Gene transfer of AIMP1 and B7.1 into epitope-loaded, fibroblasts induces tumor-specific CTL immunity, and prolongs the survival period of tumor-bearing mice. Vaccine 26:47, pages 5928-5934.
Crossref
Crossref
Michela Croce, Raffaella Meazza, Anna M. Orengo, Marina Fabbi, Martina Borghi, Domenico Ribatti, Beatrice Nico, Barbara Carlini, Vito Pistoia, Maria Valeria Corrias & Silvano Ferrini. (2008) Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen. Cancer Immunology, Immunotherapy 57:11, pages 1625-1634.
Crossref
Crossref
Y Shi, M Zou, E Y Baitei, A S Alzahrani, R S Parhar, Z Al-Makhalafi & F A Al-Mohanna. (2007) Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma. Cancer Gene Therapy 15:2, pages 101-107.
Crossref
Crossref
S. A. Nedospasov & D. V. Kuprash. (2007) Oncoimmunology: Some fundamental problems of cancer immunotherapy. Molecular Biology 41:2, pages 316-328.
Crossref
Crossref
Angelica Loskog, Christina Ninalga, Gabriella Paul-Wetterberg, Manuel de la Torre, Per-Uno Malmström & Thomas H. Tötterman. (2007) Human Bladder Carcinoma is Dominated by T-Regulatory Cells and Th1 Inhibitory Cytokines. The Journal of Urology 177:1, pages 353-358.
Crossref
Crossref
Thomas H. Totterman, Angelica Loskog & Magnus Essand. (2005) The immunotherapy of prostate and bladder cancer. BJU International 96:5, pages 728-735.
Crossref
Crossref
Ivonne van Bruggen, Delia J Nelson, Andrew J Currie, Connie Jackaman & Bruce W. S Robinson. (2005) Intratumoral Poly-N-Acetyl Glucosamine-Based Polymer Matrix Provokes a Prolonged Local Inflammatory Response That, When Combined with IL-2, Induces Regression of Malignant Mesothelioma in a Murine Model. Journal of Immunotherapy 28:4, pages 359-367.
Crossref
Crossref